november AG
november AG english
november AG still on growth track
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
Erlangen, 14 August 2003. Contrary to the general economic trend in Germany,
november AG (ISIN DE0006762909) was able to increase group revenues by pleasing
13 percent amounting to a total of TEUR 1,813 in the first half of 2003
(previous year’s period: TEUR 1,602).
In the same period of time, selling expenses rose by 9 percent amounting to TEUR
1,001 (previous year’s period: TEUR 921). They pertain to the operations of the
subsidiary PEQLAB Biotechnologie GmbH and in particular to the costs associated
with the market launch of our product security and brand protection solutions
from the identif Technology business unit. Due to the significantly expanded
marketing activities, selling expenses rose by 22 percent between the first and
second quarter 2003. The consolidated net result for the first six months 2003
improved by 37 percent to TEUR -1,590 (previous year: TEUR -2,512). Earnings per
share (EPS and DVFA/SG) amounting to EUR -0.23 were also significantly
ameliorated in comparison to last year’s result (EUR -0.37). Research and
development costs still strongly decreased to TEUR 1,736 compared to previous
year’s period (TEUR 3,064). This can be mainly attributed to the spinning off of
the therapeutic division. According to plan, the remaining divisions expanded
their R&D expenses by 30 percent. Former members of the therapeutical unit are
now employed by the spin-off responsif GmbH. Therefore, november’s average
number of employees (adjusted to full time) in the first half of 2003 was 64
compared to 89 employees in last year’s period. The influence of the spin-off
has also to be taken into account when comparing a number of key figures.
The operative result (EBIT) improved by 43 percent to TEUR -2,467 (previous
year’s period: TEUR -4,295). The balance sheet total was TEUR 26,537 on 30 June
2003 (previous year: TEUR 32,223). The equity ratio remains unchanged at 92
percent. Total short and medium term liquidity amounted to 11.4 million EUR on
30 June 2003. The executive board believes that this is a convenient basis to
accomplish break-even.
Further information: Dr. Peer Nils Schröder +49 (0)9131 750 88 868,
schroeder@november.de, www.november.de
end of ad-hoc-announcement (c)DGAP 14.08.2003
——————————————————————————–
WKN: 676290; ISIN: DE0006762909; Index:
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-
Bremen, Düsseldorf, Hannover, München und Stuttgart
140731 Aug 03
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden